Monthly pipeline update: A July news roundup

Major news on the presbyopia forefront closed out July with the FDA's approval of Lenz Therapeutics’ VIZZ (aceclidine 1.44%). The first and only FDA-approved aceclidine eye drop for presbyopia was met with other formative developments in multiple specialties in eye care, including retina, dry eye, and lid and lash. Learn the latest in our roundup of what to take away from the month of July in terms of drug and technology updates below: